Best Practices

Becerra Says Surprise Billing Rules Force Doctors Who Overcharge to Accept Fair Prices

Overpriced doctors and other medical providers who can’t charge a reasonable rate for their services could be put out of business when new rules against surprise medical bills take effect in January, and that’s a good thing, Health and Human Services Secretary Xavier Becerra told KHN, in defending the regulations. The proposed rules represent the Biden administration’s plan to carry out the No...

read more

Understanding Shoulder Pain

Deep, persistent pain in the shoulder can affect young and old alike. Young, active patients often feel that shoulder pain stems from overuse. Current exercise regimens usually emphasize strengthening the deltoid muscles, but the rotator cuff is largely ignored. If the pain is a chronic problem, with no history of a single traumatic event, the patient will usually respond to strengthening...

read more

Q & A with Dr. Steven Ullmann and Alex Azar of Miami Herbert Business School | Part 2 of 2-part series

Part 2 of a 2-Part Series (Read Part 1 HERE) One of the most established Health Executive MBA programs in the U.S. is the one offered by the University of Miami’s Patti and Allan Herbert Business School (Miami Herbert). The University's highly regarded faculty includes Dr. Steven G. Ullmann and former U.S. Secretary of Health and Human Services Alex Azar. Dr. Ullmann, a professor of health...

read more

Miami Herbert Business School’s HEMBA: A Diverse Faculty with an Unparalleled Depth of Experience | Part 1 of 2-part series

Part 1 of 2-part series Master’s programs in healthcare have become a hot commodity over the past 10 years and competition for students has grown fierce as a plethora of new programs have been added to meet rising demand. One of the most established Health Executive MBA programs in the U.S. is the one offered by the University of Miami’s Patti and Allan Herbert Business School (Miami Herbert)....

read more

How Theranos’ faulty blood tests got to market – and what that shows about gaps in FDA regulation

Theranos promised that a drop of blood could yield many health secrets. RapidEye/E+ via Getty Images ~~~~~~~~~~ One of the most high-profile trials of the year is underway to decide whether Theranos founder Elizabeth Holmes defrauded patients and investors. Her blood testing startup, once valued at almost US$10 billion, was based on a seemingly revolutionary premise. Company executives promised...

read more

Biosimilar Drugs Are Cheaper Than Biologics. Are They Similar Enough to Switch?

It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes. And after learning in 2016 that she had Crohn’s disease, a chronic inflammation of the digestive tract, she spent more than four years trying medications before getting her disease under control with a biologic drug called Remicade. So Moxley, 33,...

read more